Log in to save to my catalogue

Salivary alpha-1-antitrypsin and macrophage migration inhibitory factor may be potential prognostic...

Salivary alpha-1-antitrypsin and macrophage migration inhibitory factor may be potential prognostic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2516596913

Salivary alpha-1-antitrypsin and macrophage migration inhibitory factor may be potential prognostic biomarkers for oncologic treatment–induced severe oral mucositis

About this item

Full title

Salivary alpha-1-antitrypsin and macrophage migration inhibitory factor may be potential prognostic biomarkers for oncologic treatment–induced severe oral mucositis

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Supportive care in cancer, 2021-06, Vol.29 (6), p.2939-2946

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Aims
Evaluate the abundance of the selected targets, alpha-1-antitrypsin (A1AT) and macrophage migration inhibitory factor (MIF), and correlate these findings with the risk of developing severe oral mucositis (OM).
Materials and methods
Head and neck squamous cell carcinoma (HNSCC) patients submitted to radiotherapy (RT) or chemoradiothera...

Alternative Titles

Full title

Salivary alpha-1-antitrypsin and macrophage migration inhibitory factor may be potential prognostic biomarkers for oncologic treatment–induced severe oral mucositis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2516596913

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2516596913

Other Identifiers

ISSN

0941-4355

E-ISSN

1433-7339

DOI

10.1007/s00520-020-05805-2

How to access this item